European Archives - Page 544 of 1425 - European Medical Journal

stamp of approval

Second mpox vaccine wins FDA approval

The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection.

Common Antibiotics Linked to Risk of Life-Threatening Reactions

New study shows sulfonamides and cephalosporins carry the highest risk for serious cutaneous adverse drug reactions among antibiotics, particularly in older adults.

Barrett’s Oesophagus After Sleeve Gastrectomy: Is There a Risk?

Recent research highlights a significant increase in the risk of Barrett’s esophagus following sleeve gastrectomy, a commonly performed bariatric surgery

Liberal Transfusion Shows Comparable Outcomes in Brain Injury Recovery

A recent study finds that a liberal transfusion strategy does not improve neurological outcomes in critically ill patients with traumatic brain injury compared to a restrictive approach.

Intestinal Ultrasound Predicts Treatment Success in Paediatric Ulcerative Colitis

A study highlights the potential of intestinal ultrasound as a valuable tool for predicting treatment outcomes in children with moderate-to-severe ulcerative colitis.

Acute Myeloid Leukaemia Treatment Assessed for Patients Over 80

A multicentre study reveals the efficacy of Venetoclax with hypomethylating agents in treating acute myeloid leukemia in patients aged 80 and older.

Vutrisiran Reduces Mortality in Patients with Transthyretin Amyloidosis: ESC 2024

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.

Handshake on blue background

Novartis and Lindy Biosciences enter drug delivery partnership

The deal centres on Lindy’s microglassification technology, which facilitates high-concentration subcutaneous injections of biologic drugs.

Obesity Associated with Longer Survival in Immunotherapy-Treated Head, Neck Cancer

Obesity is linked to improved survival outcomes in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Researchers

UK government unveils £400m plan to boost life science sector

The UK Government has launched a £400m public-private investment initiative, aiming to advance the pharmaceutical and life sciences sectors.